Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -99.62% is 153% below its 5-year average of 188.84%, near the low end of its 5-year range (-149.19%–1421.66%).
149.11% below its 12-month average of -39.99%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -31.56%.
RETURN ON ASSETS (ROA)
-99.62%
RETURN ON ASSETS (ROA) AVG TTM
-39.99%
RETURN ON ASSETS (ROA) AVG 3Y
-67.06%
RETURN ON ASSETS (ROA) AVG 5Y
188.84%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-149.11%
CURRENT VS 3Y AVG
-48.55%
CURRENT VS 5Y AVG
-152.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-209.00%
vs the sector median at left
Context Therapeutics Inc.
Market Cap
$29.57M
Return on Assets (ROA)
-99.62%
TTM Avg
-39.99%
3Y Avg
-67.06%
5Y Avg
188.84%
Market Cap
$29.74M
Return on Assets (ROA)
-49.53%
TTM Avg
-17.16%
3Y Avg
-133.18%
5Y Avg
-213.67%
Market Cap
$29.37M
Return on Assets (ROA)
-102.56%
TTM Avg
-232.33%
3Y Avg
-191.42%
5Y Avg
-176.42%
Market Cap
$29.91M
Return on Assets (ROA)
-115.56%
TTM Avg
-181.38%
3Y Avg
-357.07%
5Y Avg
-299.51%
Market Cap
$30.19M
Return on Assets (ROA)
-8.99%
TTM Avg
-5.06%
3Y Avg
-16.59%
5Y Avg
-28.89%
Market Cap
$30.44M
Return on Assets (ROA)
-13.65%
TTM Avg
-19.04%
3Y Avg
-14.35%
5Y Avg
-23.11%
Market Cap
$28.47M
Return on Assets (ROA)
-45.77%
TTM Avg
-31.61%
3Y Avg
-54.99%
5Y Avg
-58.45%
Market Cap
$30.81M
Return on Assets (ROA)
-22.66%
TTM Avg
-23.43%
3Y Avg
-29.30%
5Y Avg
-40.97%
Market Cap
$28.31M
Return on Assets (ROA)
-623.61%
TTM Avg
-201.00%
3Y Avg
-2514.84%
5Y Avg
-1875.48%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | $29.57M | -99.62% | -39.99% | -67.06% | 188.84% |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -49.53% | -17.16% | -133.18% | -213.67% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -102.56% | -232.33% | -191.42% | -176.42% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | -115.56% | -181.38% | -357.07% | -299.51% |
| Rockwell Medical, Inc. (RMTI)vs › | $30.19M | -8.99% | -5.06% | -16.59% | -28.89% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.44M | -13.65% | -19.04% | -14.35% | -23.11% |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | -45.77% | -31.61% | -54.99% | -58.45% |
| MDxHealth S.A. (MDXH)vs › | $30.81M | -22.66% | -23.43% | -29.30% | -40.97% |
| OneMedNet Corporation (ONMD)vs › | $28.31M | -623.61% | -201.00% | -2514.84% | -1875.48% |
| CervoMed Inc. (CRVO)vs › | $30.92M | -116.76% | -76.53% | -78.60% | -71.54% |
ROA
-99.6%
ROE
-120.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -52.74% |
| 2024-12-31 | -27.24% |
| 2023-12-31 | -149.19% |
| 2022-12-31 | -39.08% |
| 2021-12-31 | -20.38% |
| 2020-12-31 | 1421.66% |
| 2019-12-31 | -2333.78% |
